KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.3850
-0.0344 (-8.20%)
At close: Oct 2, 2026, 4:00 PM EDT
0.3820
-0.0030 (-0.78%)
After-hours: Oct 2, 2026, 7:20 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $7.45 million as of October 2, 2026. Its market cap has decreased by -21.62% in one year.
Market Cap
7.45M
Enterprise Value
216.82K
1-Year Change
-21.62%
Ranking
Category
Stock Price
$0.39
ChartMarket Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $7.45M, a decrease of -98.27%. That is a compound annual growth rate of -35.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 7.45M | 61.87% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Azitra | 8.70M |
| FibroBiologics | 8.61M |
| Aprea Therapeutics | 8.50M |
| Traws Pharma | 8.43M |
| XTL Biopharmaceuticals | 8.16M |
| Longeveron | 8.10M |
| CNS Pharmaceuticals | 8.04M |
| Soligenix | 7.95M |